155 related articles for article (PubMed ID: 2179203)
1. A multicentre, open, clinical trial of a new intravenous formulation of fusidic acid in severe staphylococcal infections.
Portier H
J Antimicrob Chemother; 1990 Feb; 25 Suppl B():39-44. PubMed ID: 2179203
[TBL] [Abstract][Full Text] [Related]
2. Staphylococcal bacteraemia and endocarditis and fusidic acid.
Eykyn SJ
J Antimicrob Chemother; 1990 Feb; 25 Suppl B():33-8. PubMed ID: 2312444
[TBL] [Abstract][Full Text] [Related]
3. Intravenous fusidic acid ('Fucidin') in the management of severe staphylococcal infections: a review of 46 cases.
Menday AP; Marsh BT
Curr Med Res Opin; 1976; 4(2):132-8. PubMed ID: 1277881
[TBL] [Abstract][Full Text] [Related]
4. A fatal infection caused by methicillin-resistant Staphylococcus aureus acquiring resistance to gentamicin and fusidic acid during therapy.
Amirak ID; Li AK; Williams RJ; Noone P
J Infect; 1981 Mar; 3(1):50-8. PubMed ID: 6926536
[No Abstract] [Full Text] [Related]
5. Evaluation of fusidic acid in therapy of experimental Staphylococcus aureus meningitis.
Østergaard C; Yieng-Kow RV; Knudsen JD; Frimodt-Møller N; Espersen F
J Antimicrob Chemother; 2003 May; 51(5):1301-5. PubMed ID: 12697637
[TBL] [Abstract][Full Text] [Related]
6. Effects of fusidic acid on staphylococcal keratitis.
Tabbara KF; Antonios S; Alvarez H
Br J Ophthalmol; 1989 Feb; 73(2):136-9. PubMed ID: 2649148
[TBL] [Abstract][Full Text] [Related]
7. Fusidic acid in orthopaedic infections due to coagulase-negative staphylococci.
Coombs RR; Menday AP
Curr Med Res Opin; 1985; 9(9):587-90. PubMed ID: 3902374
[TBL] [Abstract][Full Text] [Related]
8. Fusidic acid resistance in community isolates of methicillin susceptible Staphylococcus aureus and the use of topical fusidic acid: a retrospective case-control study.
Mason BW; Howard AJ
Int J Antimicrob Agents; 2004 Mar; 23(3):300-3. PubMed ID: 15164973
[TBL] [Abstract][Full Text] [Related]
9. Staphylococcal bacteraemia, fusidic acid, and jaundice.
Humble MW; Eykyn S; Phillips I
Br Med J; 1980 Jun; 280(6230):1495-8. PubMed ID: 7388562
[TBL] [Abstract][Full Text] [Related]
10. Treatment of vancomycin-intermediate Staphylococcus aureus (VISA) endocarditis with linezolid.
Balkhair A; Al Muharrmi Z; Darwish L; Farhan H; Sallam M
Int J Infect Dis; 2010 Sep; 14 Suppl 3():e227-9. PubMed ID: 20005763
[TBL] [Abstract][Full Text] [Related]
11. Treatment of staphylococcal prosthetic joint infections with debridement, prosthesis retention and oral rifampicin and fusidic acid.
Aboltins CA; Page MA; Buising KL; Jenney AW; Daffy JR; Choong PF; Stanley PA
Clin Microbiol Infect; 2007 Jun; 13(6):586-91. PubMed ID: 17331125
[TBL] [Abstract][Full Text] [Related]
12. Methicillin-resistant staphylococci as an epidemiological indication for gentamicin therapy.
Ericson C; Larsson S
Acta Pathol Microbiol Scand B Microbiol Immunol; 1973; ():Suppl 241:65-8. PubMed ID: 4521609
[No Abstract] [Full Text] [Related]
13. Clinical experiences with fusidic acid in cystic fibrosis patients.
Jensen T; Lanng S; Faber M; Rosdahl VT; Høiby N; Koch C
J Antimicrob Chemother; 1990 Feb; 25 Suppl B():45-52. PubMed ID: 2312445
[TBL] [Abstract][Full Text] [Related]
14. [In vitro kinetics of the activity of fusidic acid and fluoroquinolones combinations against staphylococci according to methicillin-resistance phenotype. Implications for the treatment of osteoarticular infections].
Reynaud AE; Espaze EP; Coste-Burel M; Richet H
Pathol Biol (Paris); 1992 May; 40(5):466-70. PubMed ID: 1495828
[TBL] [Abstract][Full Text] [Related]
15. Fusidic acid as a potential antistaphylococcal agent.
Nicholson J; Chew T; Smith S
N Z Med J; 1999 Jul; 112(1091):261-2. PubMed ID: 10448991
[No Abstract] [Full Text] [Related]
16. Activity of fusidic acid against extracellular and intracellular Staphylococcus aureus: influence of pH and comparison with linezolid and clindamycin.
Lemaire S; Van Bambeke F; Pierard D; Appelbaum PC; Tulkens PM
Clin Infect Dis; 2011 Jun; 52 Suppl 7():S493-503. PubMed ID: 21546626
[TBL] [Abstract][Full Text] [Related]
17. Fusidic acid in the treatment of methicillin-resistant Staphylococcus aureus.
Whitby M
Int J Antimicrob Agents; 1999 Aug; 12 Suppl 2():S67-71. PubMed ID: 10528788
[TBL] [Abstract][Full Text] [Related]
18. Sodium fusidate.
S Afr Med J; 1969 Dec; 43(51):1537. PubMed ID: 5372049
[No Abstract] [Full Text] [Related]
19. High usage of topical fusidic acid and rapid clonal expansion of fusidic acid-resistant Staphylococcus aureus: a cautionary tale.
Williamson DA; Monecke S; Heffernan H; Ritchie SR; Roberts SA; Upton A; Thomas MG; Fraser JD
Clin Infect Dis; 2014 Nov; 59(10):1451-4. PubMed ID: 25139961
[TBL] [Abstract][Full Text] [Related]
20. Efforts to support the development of fusidic acid in the United States.
Fernandes P; Pereira D
Clin Infect Dis; 2011 Jun; 52 Suppl 7():S542-6. PubMed ID: 21546632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
